Cycle-length evidence
Kisspeptin-10 cycle length: what human studies ran
Not approved — research use onlyBLimited human data
Short answer: there is no established Kisspeptin-10 cycle length, and we found no human studies that report one.
Treatment and follow-up in human studies
No human study durations are recorded.
What has not been tested
- On-and-off schedules or breaks between courses.
- Repeated courses and long-term exposure beyond the periods listed.
- Kisspeptin-10 combined with other compounds, unless a study above says so.
Frequently asked questions
Is there an established Kisspeptin-10 cycle length?
No. We found no human studies that report a treatment duration for Kisspeptin-10.
What is the longest human study of Kisspeptin-10?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
References
- Drugs@FDA application data queried through openFDA for kisspeptin (no matching application record returned on 22 October 2026) openFDA / Drugs@FDA. 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the FD&C Act (categories 1, 2 and 3; updated May 14, 2026) FDA. 2026
- International Standard: Prohibited List 2026 World Anti-Doping Agency. 2026
- Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system Br J Pharmacol. 2007
- Metastin suppresses the motility and growth of CHO cells transfected with its receptor Biochem Biophys Res Commun. 2001
- Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men J Clin Endocrinol Metab. 2011
- Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men Eur J Endocrinol. 2026
- Kisspeptin Administration Stimulates Reproductive Hormones but Does Not Affect Anxiety in Humans J Clin Endocrinol Metab. 2025
- Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial JAMA Netw Open. 2023
- Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial JAMA Netw Open. 2022
- PubChem compound record for kisspeptin-10 (CID 25240297; CAS 374675-21-5) PubChem. 2026